• Privacy policy
  • T&C’s
  • About Us
    • FAQ
    • Meet the Team
  • Contact us
  • Guest Content
TLE ONLINE SHOP!
  • TLE
  • News
  • Politics
  • Opinion
    • Elevenses
  • Business
  • Food
  • Travel
  • Property
  • JOBS
  • All
    • All Entertainment
    • Film
    • Sport
    • Tech/Auto
    • Lifestyle
      • Horoscopes
    • Lottery Results
      • Lotto
      • Thunderball
      • Set For Life
      • EuroMillions
No Result
View All Result
The London Economic
SUPPORT THE LONDON ECONOMIC
NEWSLETTER
  • TLE
  • News
  • Politics
  • Opinion
    • Elevenses
  • Business
  • Food
  • Travel
  • Property
  • JOBS
  • All
    • All Entertainment
    • Film
    • Sport
    • Tech/Auto
    • Lifestyle
      • Horoscopes
    • Lottery Results
      • Lotto
      • Thunderball
      • Set For Life
      • EuroMillions
No Result
View All Result
The London Economic
No Result
View All Result
Home Lifestyle Health

Statins ‘can prevent liver cancer’

Researchers found that the cholesterol lowering pills can also help prolong the lives of patients with chronic viral hepatitis

Steve Beech by Steve Beech
2019-08-19 22:00
in Health, Lifestyle
FacebookTwitterLinkedinEmailWhatsapp

Statins can prevent liver cancer, according to a new study.

Researchers found that the cholesterol lowering pills can also help prolong the lives of patients with chronic viral hepatitis.

They were investigating whether statins, which lower cholesterol levels and are primarily used to prevent cardiovascular disease, could also prevent liver cancer.

Statins are either fat-soluble, known as lipophilic, or water-soluble, known as hydrophilic.

But the role that the difference plays for potentially preventing cancer has been unclear.

Chronic viral hepatitis – hepatitis B and C – are severe conditions with an increased risk of liver cancer.

It is possible to treat hepatitis B and cure hepatitis C, but there is no treatment that can prevent liver cancer in people whose liver has been damaged by hepatitis.

The new study, published in the journal Annals of Internal Medicine, involved more than 63,000 patients with chronic hepatitis B and C.

Among these, 8,334 patients used statins, of which 6,554 used fat-soluble statins – such as atorvastatin, simvastatin, fluvastatin or lovastatin – while 1,780 used water-soluble statins, such as pravastatin or rosuvastatin.

RelatedPosts

Lucky Numbers and Horoscopes for today 4 June 2023

Lucky Numbers and Horoscopes for today 3 June 2023

Keeping Your Business Spotless: The Benefits of Commercial Carpet Cleaning in London

Lucky Numbers and Horoscopes for today 2 June 2023

Over a 10-year follow-up period, liver cancer developed in 3.3 per cent of the patients taking fat-soluble statins compared with 8.1 per cent of the patients not on statins.

The Swedish research team found that, after other factors were taken into account, it corresponded to a 44 per cent lower risk of liver cancer.

Patients on fat-soluble statins also had a lower mortality rate after 10 years than patients who had never taken statins.

Study leader Professor Jonas Ludvigsson, of the Karolinska Institutet, said: “Previous research has indicated that statins may play a role in preventing liver cancer.

“Now we have confirmed that and shown that it is the fat-soluble statins that have the greatest effect.”

He said the patients who used water-soluble statins also had a lower mortality rate, but did not have a reduced incidence of liver cancer.

Prof Ludvigsson added: “In addition, fat-soluble statins had a greater effect on mortality than water-soluble statins had.”

He said the research group is now going to study whether fat-soluble statins can affect the risk of liver cancer and mortality in conjunction with other types of liver disease as well.

Content Protection by DMCA.com

Subscribe to our Newsletter

View our  Privacy Policy and Terms & Conditions

Trending on TLE

  • All
  • trending

Elevenses: The Thing About Wrexham’s Cinderella Story

Elevenses: Exposing the Tories’ Deepfake Illegal Immigration Bill

Elevenses: Rishi’s Finest Hour

More from TLE

Student medics babysitting for NHS staff during COVID-19 pandemic

‘Johnson for sale’: Kwarteng promised fake firm access to ex-PM for £10k a day

Harry arrives back in UK for Duke of Edinburgh’s funeral

Peers reject Johnson’s law-breaking Brexit bill as Boothroyd blasts Boris

Vineyard enjoys its earliest harvest in over 35 years – with grape yield up by over a third

Government to take over all rail franchises for “at least” six months

Johnson promised 25,000 contact tracers by June 1st but who are they?

Two in five Brits view Johnson as corrupt

What pandemic? World’s top 15 hedge funders made £17 billion last year

“Genuine concern” over Cardiff City new record signing after private plane goes missing near English Channel

About Us

TheLondonEconomic.com – Open, accessible and accountable news, sport, culture and lifestyle.

Read more

Contact

Editorial enquiries, please contact: [email protected]

Commercial enquiries, please contact: [email protected]

Address

The London Economic Newspaper Limited t/a TLE
Company number 09221879
International House,
24 Holborn Viaduct,
London EC1A 2BN,
United Kingdom

SUPPORT

We do not charge or put articles behind a paywall. If you can, please show your appreciation for our free content by donating whatever you think is fair to help keep TLE growing and support real, independent, investigative journalism.

DONATE & SUPPORT

© 2019 thelondoneconomic.com - TLE, International House, 24 Holborn Viaduct, London EC1A 2BN. All Rights Reserved.




No Result
View All Result
  • Home
  • News
  • Politics
  • Business
  • Sport
  • Entertainment
  • Lifestyle
  • Food
  • Travel
  • JOBS
  • More…
    • Elevenses
    • Opinion
    • Property
    • Tech & Auto
  • About Us
    • Meet the Team
    • Privacy policy
  • Contact us

© 2019 thelondoneconomic.com - TLE, International House, 24 Holborn Viaduct, London EC1A 2BN. All Rights Reserved.